Maimon Yossi Insider Trades

Insider Trading History

Track insider trading activity for Maimon Yossi. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ayala Pharmaceuticals
Ayala Pharmaceuticals AYLA
Cfo, Secretary And Treasurer
Holding Value $0 0 shares
Last Trade
Jan 19, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$16.1k 31,950 shares
$0.50
$0.53
Ayala Pharmaceuticals
Ayala Pharmaceuticals AYLA
Cfo, Secretary & Treasurer
Holding Value $37.3k 69,872 shares
Last Trade
May 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$106k 50,000 shares
$2.11
$0.53
Ayala Pharmaceuticals
Ayala Pharmaceuticals AYLA
Cfo, Secretary & Treasurer
Holding Value $17.1k 31,950 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$291k 31,950 shares
$9.11
$0.53
Ayala Pharmaceuticals
Ayala Pharmaceuticals AYLA
Cfo, Secretary & Treasurer
Holding Value $10.6k 19,872 shares
Last Trade
Jan 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$216k 19,170 shares
$11.26
$0.53
Ayala Pharmaceuticals
Ayala Pharmaceuticals AYLA
Cfo, Secretary & Treasurer
Holding Value $6.06k 11,352 shares
Last Trade
May 07, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.53
Ayala Pharmaceuticals
Ayala Pharmaceuticals AYLA
CFO
Holding Value $0 0 shares
Last Trade
May 07, 2020 Sale
No data
No data
$0.53
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Chief Financial Officer
Holding Value $1.37M 700,000 shares
Last Trade
Sep 13, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.57M 700,000 shares
$5.10
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vice President & CFO
Holding Value $19.6k 10,000 shares
Last Trade
Dec 14, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$78k 10,000 shares
$7.80
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Chief Financial Officer
Holding Value $490k 250,000 shares
Last Trade
Mar 23, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.3M 250,000 shares
$17.20
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vice President & CFO
Holding Value $363k 185,000 shares
Last Trade
Jul 16, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.6M 185,000 shares
$57.20
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
May 02, 2012 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.83M 125,964 shares
$70.10
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
May 02, 2012 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.83M 125,964 shares
$70.10
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Chief Financial Officer
Holding Value $247k 125,964 shares
Last Trade
May 02, 2012 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.83M 125,964 shares
$70.10
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Oct 07, 2010 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.57M 77,769 shares
$97.30
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Oct 07, 2010 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$756k 7,769 shares
$97.30
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Oct 07, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.81M 70,000 shares
$97.30
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Chief Financial Officer
Holding Value $149k 75,964 shares
Last Trade
Oct 07, 2010 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.57M 77,769 shares
$97.30
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Sep 07, 2010 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.73M 70,000 shares
$81.80
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Sep 07, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.58M 31,500 shares
$81.80
$1.96
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Vp, Chief Financial Officer
Holding Value $301k 153,733 shares
Last Trade
Sep 07, 2010 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.73M 70,000 shares
$81.80
$1.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up